Cargando…

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models

Diffuse large B-cell lymphomas (DLBCLs) are heterogeneous diseases growing either in nodal or extranodal locations including the central nervous system. One key issue is to decipher the prognostic value of immune cells infiltrating these tumors as DLBCLs developing in sanctuaries are more aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galand, Claire, Donnou, Sabrina, Molina, Thierry Jo, Fridman, Wolf Herman, Fisson, Sylvain, Sautès-Fridman, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343266/ https://www.ncbi.nlm.nih.gov/pubmed/22566974 http://dx.doi.org/10.3389/fimmu.2012.00098

Ejemplares similares

Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies
por: Donnou, Sabrina, et al.
Publicado: (2012)

Th17 Cells Are Involved in the Local Control of Tumor Progression in Primary Intraocular Lymphoma
por: Galand, Claire, et al.
Publicado: (2011)

Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment
por: Ben Abdelwahed, Rym, et al.
Publicado: (2013)

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
por: Cosette, Jeremie, et al.
Publicado: (2016)

Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis
por: Fisson, Sylvain, et al.
Publicado: (2013)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

Characteristics of tertiary lymphoid structures in primary cancers
por: Goc, Jérémy, et al.
Publicado: (2013)

The European Academy of Tumor Immunology: Bridging fields, continents and generations
por: Kroemer, Guido, et al.
Publicado: (2012)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

Tumor Immunology, toward a Success Story?
por: Sautès-Fridman, Catherine
Publicado: (2015)

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
por: Sautès-Fridman, Catherine, et al.
Publicado: (2016)

Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serum
por: Yagi, Hirokazu, et al.
Publicado: (2018)

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer
por: Senovilla, Laura, et al.
Publicado: (2012)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020)

Complement System: Promoter or Suppressor of Cancer Progression?
por: Revel, Margot, et al.
Publicado: (2020)

Metastatic Melanomas Express Inhibitory Low Affinity Fc Gamma Receptor and Escape Humoral Immunity
por: Cohen-Solal, Joel F. G., et al.
Publicado: (2010)

Lung Tumor Microenvironment Induces Specific Gene Expression Signature in Intratumoral NK Cells
por: Gillard-Bocquet, Mélanie, et al.
Publicado: (2013)

B cells and cancer: To B or not to B?
por: Fridman, Wolf Herman, et al.
Publicado: (2020)

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
por: Becht, Etienne, et al.
Publicado: (2016)

Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
por: Becht, Etienne, et al.
Publicado: (2016)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012)

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine
por: Petitprez, Florent, et al.
Publicado: (2018)

Editorial: Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer
por: Sautès-Fridman, Catherine, et al.
Publicado: (2022)

The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression
por: Petitprez, Florent, et al.
Publicado: (2020)

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
por: Truxova, Iva, et al.
Publicado: (2018)

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

The clinical role of the TME in solid cancer
por: Giraldo, Nicolas A., et al.
Publicado: (2018)

The Ultimate Goal of Curative Anti-Cancer Therapies: Inducing an Adaptive Anti-Tumor Immune Response
por: Fridman, Wolf H., et al.
Publicado: (2011)

Trial watch: Dendritic cell-based interventions for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial watch: Peptide vaccines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

Revisiting immune escape in colorectal cancer in the era of immunotherapy
por: Ijsselsteijn, Marieke Erica, et al.
Publicado: (2019)

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
por: Becht, Etienne, et al.
Publicado: (2015)

El cerebro móvil : de la inmunidad al sistema inmune /
por: Fridman, Wolf H. (Wolf Herman)
Publicado: (1997)

Presentation of Antigen in Immune Complexes Is Boosted by Soluble Bacterial Immunoglobulin Binding Proteins
por: Léonetti, Michel, et al.
Publicado: (1999)

Trial watch: Oncolytic viruses for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial watch: Monoclonal antibodies in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7uv0ldokh5qjoeji5nqniml2f7